- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
PriorityBABY Family First Program Launches From Priority Health
This newest offering from Priority Health educates and supports parents, caregivers, and their children through the second birthday through providing resources that focus on infant health and safety.
Grand Rapids, Michigan — On March 7, Priority Health, the nationally recognized nonprofit health benefits company, announced the launch of PriorityBABY, which builds upon the success of PriorityMOM, a similar initiative that celebrated its 2-year anniversary last year.
PriorityBABY aims to offer comprehensive education and support services to enrolled parents and caregivers who have newborn dependents through the child's second birthday. The initiative's focus is infant health and safety, with resources that include physician appointment reminders, cost and coverage plan information, and health care tips.
“The physical, mental and emotional development of a child is very important in the first two years of life, and we understand that parents may encounter challenges and have questions about cost of care and coverage,” said Kristen Burleson, director of health plan quality improvement for Priority Health. “That’s why we developed PriorityBABY—to provide customized support and education for our members, from birth to toddlerhood.”
Read more about the program here.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
